Shu‐Heng Jiang

3.4k citations
75 papers · 2.1k indexed · h-index 26
Topics
Cancer, Hypoxia, and Metabolism (17 papers)RNA modifications and cancer (15 papers)Cancer, Stress, Anesthesia, and Immune Response (9 papers)
Partner nations
ChinaJapanSweden

In The Last Decade

Shu‐Heng Jiang

73 papers receiving 2.1k citations

Peers

Shu‐Heng Jiang
Comparison fields: 5 of 96
  • Molecular Biology 1.2k
  • Cancer Research 792
  • Oncology 439
  • Immunology 335
  • Pulmonary and Respiratory Medicine 287
Replace Georg Karpel‐Massler with:
Georg Karpel‐Massler Germany
Hongwei Xia China
Dou Ke-feng China
Chenfang Dong China
Julie L. Boerner United States
Maode Wang China
Denise J. Spring United States
Nicole S. Spoelstra United States
Smitha Pillai United States
Zhifeng Dong China
Shu‐Heng Jiang relative to Georg Karpel‐Massler Germany Georg Karpel‐Massler's profile →
Citations per field
00.5×7.5×
Georg Karpel‐Massler · 1×
Citations per year

Countries citing papers authored by Shu‐Heng Jiang

Since Specialization
Citations

This map shows the geographic impact of Shu‐Heng Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Heng Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Heng Jiang more than expected).

Fields of papers citing papers by Shu‐Heng Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu‐Heng Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Heng Jiang. The network helps show where Shu‐Heng Jiang may publish in the future.

Co-authorship network of co-authors of Shu‐Heng Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Shu‐Heng Jiang. A scholar is included among the top collaborators of Shu‐Heng Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu‐Heng Jiang. Shu‐Heng Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 3
3 4
4 12
5 1
6 14
7 16
8 12
9 27
10 87
11 20
12 8
13 28
14 27
15 162
16 76
17 22
18 90
19 31
20 10

About Shu‐Heng Jiang

Shu‐Heng Jiang is a scholar working on Cancer Research, Molecular Biology and Cell Biology, having authored 75 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (17 papers), RNA modifications and cancer (15 papers) and Cancer, Stress, Anesthesia, and Immune Response (9 papers). The work is most often cited by research in Cancer Research (792 citations), Molecular Biology (1.2k citations) and Oncology (439 citations). Shu‐Heng Jiang has collaborated with scholars based in China, Japan and Sweden. Frequent co-authors include Zhigang Zhang, Li-Peng Hu, Xu Wang, Yahui Wang, Xiaomei Yang, Rongkun Li, Qin Yang, Jun Li, Ye Du and Jun Li. Their work appears in journals such as Nature Communications, Gastroenterology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026